Forest Pharmaceuticals recalls
Forest Pharmaceuticals appears in 6 official U.S. recall notices indexed by RecallRadar, most recently on 2014-10-29.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
- Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest…
FDA Drug · Class II · 2014-10-29 · Forest Pharmaceuticals - Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only
FDA Drug · Class II · 2014-07-09 · Forest Pharmaceuticals - Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc., Under license from Janssen Pharm…
FDA Drug · Class II · 2014-05-28 · Forest Pharmaceuticals - Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, Forest Pharmaceutical…
FDA Drug · Class III · 2014-02-12 · Forest Pharmaceuticals - Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titrat…
FDA Drug · Class III · 2014-02-12 · Forest Pharmaceuticals - Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, NDC…
FDA Drug · Class III · 2014-02-12 · Forest Pharmaceuticals